NMPA accepts clinical trial application for monkeypox vaccine
chinadaily.com.cn |
Updated: 2023-07-14 19:44
Share
Share - WeChat
The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.
- Anhui Medical University celebrates centennial milestone
- Capital Airlines resumes Qingdao-Vancouver direct flights
- World's tallest tower for gauging wind completed
- Heritage plan stresses digital tech, cooperation
- Shanghai airport opens exhibition of Asia's largest fin whale skeleton
- China's railway passenger trips hit record single-day high
